User:Rassac7/OLES2019/draft

= BioCeuticals = Bioceuticals is one of Australia's leading provider of nutritional and therapeutic dietary supplements range produced for practitioner use only.

Dietary Supplementation
Dietary supplementation has proven to be an extremely popular consumer development, as well as a beneficial business venture. In todays Australian market, vitamin and dietary supplementation generated an estimated revenue level of up to $2.33 billion dollars in 2015.

This economic boost can be attributed to supplementation meeting consumer needs in daily life and performance areas. Dietary supplementation and vitamins aid micronutrient deficiencies for the average person. Supplementation also benefits performance by promoting training consistency, and intensity adaptations. This prospect is furthered by encouraging methods of recovery and injury prevention for athletes, including reducing muscle fatigue and tension, enhancing muscle repair. Overall, dietary supplementation presents a strategic approach and popular consumer pathway for competitive performance and daily nutritional aid.

Consumer knowledge is limited regarding risk association with supplement consumption. Unnecessary consumption of supplementation or excess consumption may be harmful to consumers and detrimentally affect performance or lead to the approach of toxicity levels in the blood. Undirected supplementation consumption should be avoided by consumers and label reading is instructed. Consumers can be mislead by evidence poor marketing ventures and company communication is low regarding potential supplement contamination. Limited awareness of this can impact the individual, and may inhibit athletic performance or lead to drug test failure.

History (Founders)
BioCeuticals is owned by Blackmores Limited and was acquired on July 2nd 2012 for $40 million, having similar goals and philosophical prospects. Despite company relations, BioCeuticals is a strictly practitioner-only range and has been committed to be continued as an independent business venture.

Verifiability
This article will promote verifiability by using factual and reputable information collected from peer-reviewed journal articles and university literature materials. All of which will be recollected and appropriately cited below in the bibliography attached to this article.

Notability
This article will endeavour to be notable to the widespread global audience. This will be achieved by providing knowledgeable information regarding Australian pharmaceutical manufacturing and delivery procedures. Furthermore, by providing foundational and structural information for health practitioners and small businesses wanting to expand national and international connections and communications involving dietary supplementation.

Neutrality
This article will present non-bias information to consumers and health practitioners and providers. In no way will this article display branded marketing or target advertising, and will enforce beneficial product information, and critical judgement, including product recalls and consumer feedback.

No Original Research
The information in this article will be written from the authors point of view, with contributing ideas from fellow scholars which will be appropriately cited and recognised.